Today: 7 February 2026
Subscribe
Browse Category

Health Insurance News 3 January 2026 - 13 January 2026

UnitedHealth (UNH) stock falls on Senate Medicare report as earnings near

UnitedHealth (UNH) stock falls on Senate Medicare report as earnings near

New York, Jan 12, 2026, 17:54 EST — After-hours Shares of UnitedHealth Group dropped Monday following a U.S. Senate committee report accusing the insurer of using aggressive risk-adjustment coding to increase Medicare Advantage payments. The stock closed down nearly 2% at $337.15, then edged up about 1% to $340.51 in after-hours trading. The report intensifies scrutiny of UnitedHealth’s Medicare billing practices, coming after the company disclosed last year it was cooperating with U.S. Justice Department inquiries. (Reuters) The timing is crucial since Medicare Advantage drives big profits for major insurers, and Washington is once again scrutinizing how these plans receive
13 January 2026
····
UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date

UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date

New York, Jan 9, 2026, 19:28 EST — After-hours UnitedHealth Group shares fell roughly 0.8% on Friday, lingering around $344 in after-hours trading as U.S. lawmakers intensified scrutiny of major insurers ahead of hearings scheduled for later this month. (stockanalysis.com) The hearings are significant as policy uncertainty is creeping back into managed care valuations. Investors have promptly pushed down the group whenever Washington discusses premiums, subsidies, or regulation. UnitedHealth faces tricky timing. It’s gearing up to update guidance for 2026 just as lawmakers prepare to press the company on costs and coverage issues. Leaders of the House Energy and Commerce
10 January 2026
·······
UnitedHealth (UNH) stock slips as House sets CEO hearing and Senate deadline looms

UnitedHealth (UNH) stock slips as House sets CEO hearing and Senate deadline looms

New York, Jan 9, 2026, 12:57 EST — Regular session UnitedHealth Group shares edged lower Friday after leaders of a U.S. House committee set a Jan. 22 hearing that will summon CEO Stephen Hemsley to Capitol Hill. The stock fell 0.7% to $344.30 by midday, and CVS Health, Cigna and Elevance were also down. The timing matters. Washington is turning the spotlight back on health insurers right as investors gear up for a busy stretch of earnings and guidance, when companies usually put numbers around medical costs and pricing. UnitedHealth has its own deadline coming up. The company is set
9 January 2026
···
Oscar Health stock steadies premarket after ACA subsidies vote; UBS lifts rating

Oscar Health stock steadies premarket after ACA subsidies vote; UBS lifts rating

New York, Jan 9, 2026, 05:47 EST — Premarket Oscar Health shares were flat at $16.90 in premarket trading on Friday, after rising 2.6% in the prior session, as investors weighed a U.S. House vote to restore expired Affordable Care Act subsidies and fresh analyst commentary. (Investing.com) The subsidies, a form of tax credit that lowers monthly premiums for many people who buy coverage through the ACA marketplaces, are a live wire for insurers like Oscar that sell heavily on the exchanges. They lapsed at the end of 2025, and the sticker shock is already showing up in what consumers
9 January 2026
····
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

New York, Jan 8, 2026, 20:57 (ET) — Market closed U.S. House lawmakers have called on UnitedHealth Group Incorporated (UNH.N) and four other major insurers to testify on coverage affordability later this month, signaling growing Washington scrutiny. UnitedHealth shares rose 1.5% to close at $346.85 on Thursday. The House Energy and Commerce Committee and the Ways and Means Committee extended invitations to UnitedHealth, CVS Health, Cigna, Elevance and Ascendia for testimony on Jan. 22. Reuters The timing is sensitive. Congress is once again locked in a dispute over subsidies under the Affordable Care Act, known as Obamacare, a debate that
9 January 2026
·······
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

New York, January 8, 2026, 13:30 (ET) — Regular session UnitedHealth Group Incorporated shares rose on Thursday after U.S. House lawmakers invited the CEOs of major health insurers to testify on January 22 about coverage affordability, as Republicans debate whether to extend Affordable Care Act subsidies and President Donald Trump has said he plans to meet insurers. The stock was up 1.3% at $346.11 by early afternoon, after trading between $339.99 and $347.79. CVS Health, Cigna and Elevance Health, also named for the hearing, were higher. Reuters The invitation puts Washington back in the middle of the managed-care trade. Hearings
8 January 2026
·······
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

New York, January 7, 2026, 11:10 EST — Regular session UnitedHealth Group Incorporated shares fell more than 2% on Wednesday, tracking a broader retreat in managed-care insurers. The stock was down $8.53 at $340.44 in late morning trading, while Humana slid 1.4% and Cigna dropped 2.1%. The move comes with investors bracing for UnitedHealth’s full-year results later this month, when the company is due to set out 2026 guidance. A key focus is the medical care ratio — the share of premium revenue that goes to medical claims — after a stretch of elevated utilization across the sector. UnitedHealth Group
7 January 2026
··········
UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

New York, January 6, 2026, 17:51 EST — After-hours UnitedHealth Group Incorporated shares rose on Tuesday after Sky News reported private equity firm TPG was close to buying the insurer’s Optum UK unit. The stock ended the regular session up $7.03, or about 2%, at $348.97. Reuters The report lands weeks before UnitedHealth is set to post full-year results and give 2026 financial guidance, a read-through on medical cost trends and pricing across its insurance and services businesses. UnitedHealth has said it will report on Jan. 27, before the market opens, and host a conference call at 8 a.m. ET.
7 January 2026
····
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

New York, January 5, 2026, 11:37 EST — Regular session UnitedHealth Group Inc shares were up 0.8% at $338.94 in late-morning trading on Monday after Barclays raised its price target on the health insurer. The stock has traded between $333.86 and $340.29 so far, with about 2.4 million shares changing hands. The call hits with UnitedHealth set to release full-year 2025 results and 2026 financial guidance on Jan. 27 before the market opens. The company said it will host an 8:00 a.m. ET teleconference with analysts and investors the same day. UnitedHealth Group That timing matters because investors want a
5 January 2026
········
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

NEW YORK, Jan 4, 2026, 17:40 ET — Market closed UnitedHealth Group (UNH) shares ended Friday up 1.9% at $336.40, closing out the first session of the year with a firm tone in managed care. The move matters because investors are now lining up around the next big waypoint: UnitedHealth’s full-year results and 2026 outlook. The company said it will report before the market opens on Jan. 27 and host a conference call at 8 a.m. ET. UnitedHealth Group That guidance will be scrutinized for any sign that medical costs are easing, particularly in Medicare Advantage — privately run plans
5 January 2026
·······
UnitedHealth (UNH) stock closes up 1.9% to start 2026 as earnings loom

UnitedHealth (UNH) stock closes up 1.9% to start 2026 as earnings loom

New York, Jan 3, 2026, 10:53 ET — Market closed UnitedHealth Group Incorporated shares rose 1.9% on Friday to close at $336.40, extending a New Year rebound for the Dow component after it traded between $327.50 and $340.21. The move matters now because UnitedHealth is set to deliver its next major catalyst this month: full-year 2025 results and 2026 financial guidance on Jan. 27, before the market opens, the company said. It will host a conference call at 8 a.m. ET. UnitedHealth Group The broader tape also turned positive in the first trading session of 2026, with the Dow up
3 January 2026
·····
UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

NEW YORK, Jan 2, 2026, 18:00 ET — After-hours UnitedHealth Group Incorporated shares rose 1.9% to $336.40 at Friday’s close and were up about 0.2% in after-hours trading near $337.10. The stock ranged from $327.50 to $340.26 in the session as 2026 got underway. StockAnalysis The next catalyst is close. UnitedHealth will report full-year 2025 results and provide 2026 guidance on Jan. 27 before the market opens, followed by an 8 a.m. ET conference call, the company said. UnitedHealth Group That guidance lands as investors watch for signs that a tough cost cycle is easing and that the company’s operational
3 January 2026
·····
1 2 3 4 5 6 7

Stock Market Today

Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

7 February 2026
Macquarie Group shares fell 2.17% to A$207.83 Friday, marking a third straight decline as the ASX 200 slid 2%. Australia’s regulator trimmed liquidity requirements for Macquarie Bank after improvements in controls. Macquarie Asset Management announced two UK utility deals, including full ownership of Last Mile Infrastructure and the purchase of Energy Assets Group. Investors await Tuesday’s operational briefing.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 1:07 AM EST Crude Oil Prices Rise on Dollar Weakness, Geopolitical Tensions February 7, 2026, 12:52 AM EST. Crude oil prices edged higher on Friday, supported by a weaker U.S. dollar and escalating geopolitical risks in the Middle East. March WTI crude gained 0.41%, rebounding from early losses, while gasoline prices rose 1.38%. Doubts over a U.S.-Iran nuclear deal loom after reports of Iran's refusal to halt uranium enrichment, raising the risk of military action and potential disruption of vital shipping routes. Additionally, a surge in U.S. consumer
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Go toTop